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Abstract Human synovium was analyzed for the possible 
expression of cartilage oligomeric matrix protein (COMP). 
Immunostaining with polyclonal antiserum to COMP demon-
strated positive staining within the synovial cells and immediately 
subjacent connective tissue, with less intense staining in the 
deeper connective tissue. Western blot analysis using either 
polyclonal or monoclonal antibodies to human COMP confirmed 
the presence of COMP by immunoreactive bands with the same 
molecular mass (approximately 110 kDa) as purified articular 
cartilage COMP. PCR using oligonucleotides that span human 
COMP exons 7-13 revealed identical amplification products 
from cDNA prepared from either human chondrocytes or 
synovium. Northern blot analysis using a biotinylated-probe to 
human COMP, spanning exons 12-13, also reveal an identical 
hybridization product to either human chondrocyte or synovium 
total RNA. Human synovium should be considered as a potential 
tissue source of COMP in any investigation of biological 
markers of cartilage metabolism. 
© 1997 Federation of European Biochemical Societies. 
1. Introduction 
Cartilage oligomeric matrix protein (COMP) is an abun-
dant, homopentameric, non-collagenous component of artic-
ular cartilage with a bouquet-like molecular structure [1-3]. 
Recent reports suggest that measurements of C O M P in serum 
or synovial fluid serve as a marker of cartilage metabolism. 
Saxne and Heinegard were the first to report elevated levels of 
C O M P , as measured by enzyme-linked immunoassay, in the 
knee joint synovial fluids of patients with reactive rheumatoid 
arthritis [4]. In the same study, they noted a significant in-
crease in serum C O M P levels in patients with juvenile chronic 
arthritis compared to healthy children. Sharif et al. reported 
that serum C O M P levels increased during the first year in 
patients with radiographic progression of arthritis compared 
to no increase in serum C O M P levels in patients without 
radiographic progression [5]. Using discriminate analysis, 
they demonstrated that serum levels of C O M P greater than 
3.17 (ig/ml had a 70% sensitivity and a 78% specificity in 
predicting disease progression. In both human osteoarthritic 
and rheumatoid arthritic joints, C O M P has been observed to 
degrade in the cartilaginous matrix, and intact C O M P and 
degraded fragments are released into the synovial fluid [6]. 
More recently, it has been shown that C O M P fragments 
rather than total C O M P content, may be more indicative of 
cartilage degradation, since increased levels of C O M P frag-
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ments have been detected in synovial fluids from patients 
with either osteoarthritis or rheumatoid arthritis [6,7] 
Although initially believed to be a cartilage-specific mole-
cule, C O M P has also been detected in tendon, albeit in much 
lower amounts [8]. Critical for any marker of cartilage metab-
olism is the knowledge of its tissue distribution and the rate of 
the marker 's secretion, degradation, and clearance from syno-
vial fluid [9]. Below we describe the expression of C O M P by 
another non-cartilage source that may have important rami-
fications for synovial fluid and/or serum C O M P measure-
ments. 
2. Material and methods 
Human COMP was purified from normal human articular cartilage 
as described previously [6], Protein concentrations were determined 
using the bicinchoninic acid protein assay (Pierce Chemical Co.) 
with BSA as a standard. SDS-polyacrylamide gel electrophoresis 
(SDS-PAGE) was performed on gradient gels of 4-15% polyacryl-
amide according to the protocol of Laemmli [10]. Reduction of disul-
fide bonds was achieved by addition 2.5% (v/v) 2-mercaptoethanol in 
the sample buffer. Gels were either stained with Coomassie Brilliant 
Blue or subjected to electrophoretic transfer to nitrocellulose as de-
scribed by Towbin et al. [11]. Polyclonal antiserum to COMP, purified 
from bovine and human articular cartilage, was raised in rabbits as 
described previously [6]. Monoclonal antibodies to human COMP 
were raised in rats; cell culture supernatant from the hybridomas 
were used for immunological assays. Immunoblots were developed 
with either monoclonal or polyclonal antiserum to human COMP, 
followed by a secondary antirat or antirabbit horseradish peroxidase 
conjugated antibody and ECL chemiluminesence (Amersham). 
Human synovium from five patients undergoing knee replacement 
surgery for non-inflammatory arthritis were divided into three por-
tions. One portion of the material was fixed for 24 h in fresh 4%> 
paraformaldehyde in 50 mM phosphate, 0.15 M NaCl, pH 7.4 
(PBS) at 4°C for immunostaining. Specimens were dehydrated, em-
bedded in paraffin, sectioned (5 urn), adsorbed to silanized oven-dried 
glass slides, deparaffinized, and hydrated to 0.1% bovine serum albu-
min in PBS. Sections were treated with either polyclonal antiserum to 
human COMP, preimmune rabbit serum (control), rat monoclonal 
antibody to human COMP, or rat monoclonal antibody to an irrele-
vant antigen (control), followed by incubation with either a biotiny-
lated goat antirabbit or rabbit antirat antibody (Biogenex), respec-
tively, for 30 min at room temperature. After washing with PBS, 
sections were incubated at room temperature with alkaline phospha-
tase-conjugated streptavidin (Biogenex) for 30 min, developed with 
Vector Red I (Vector) in 0.01 M Tris-HCl, pH 8.2, and counterstained 
with Mayer's Hematoxylin (Sigma). 
A second portion of the tissue, approximately 1 g wet weight, was 
frozen to —70°C and then homogenized (Polytron) in 10 ml of ice-
cold 50 mM Tris-HCl, 0.15 M NaCl, pH 7.4, containing 10 mM 
EDTA, 1 mM PMSF, 2 mM NEM. Samples were centrifuged for 
30 min at 8000 rpm, 4°C. The supernatants were subjected to gel 
electrophoresis and western blotting. 
A third portion of the samples (approximately 100 mg) was homo-
genized (Polytron) in 1 ml TRIzol reagent and total RNA-isolated 
(mRNA Isolation System, Life Technologies) according to the man-
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ufacturer's specifications. Total RNA then served as a template for 
first-strand cDNA synthesis through reverse transcriptional (RT) re-
action using the superscript preamplification system (Life Technolo-
gies). The cDNA then was used as a template for PCR amplification 
of an internal sequence of COMP mRNA from 742-1363 base pairs 
using oligonucleotides GCA TGC AGA CTG CGT CCT AG and 
GTC CCG AGA CTC CTG ATG TC. PCR products were analyzed 
by agarose gel electrophoresis and stained with ethidium bromide. 
Isolated adult and fetal human chondrocytes also had total RNA 
isolated by the same method. Briefly, human chondrocytes were iso-
A 
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lated from articular cartilage slices by sequential enzymatic digestion 
with trypsin (2 mg/ml) (Worthington Biochemical Co.), hyaluronidase 
(0.5 mg/ml) (Sigma), then collagenase (1.5 mg/ml) (Worthington Bio-
chemical Co.) in Ham's F-12 media containing gentamycin (50 |J,g/ml). 
The isolated cells were allowed to recover in spinner culture for 24 h, 
and then total RNA-isolated [1]. 
For Northern blot analysis, both synovium and cartilage total 
RNA were resolved on 1% agarose gels electrophoresis and trans-
ferred to nylon membrane by capillary transfer. A double-stranded 
human COMP 84-base pair biotinylated-labeled nucleic acid probe 
Fig. 1. Localization of COMP from human synovium using immunostaining with polyclonal antiserum to COMP (A) demonstrated positive 
staining within the synovial cells and immediately subjacent connective tissue, with less intense staining in the deeper connective tissue. Control 
sections with preimmune serum showed no staining (B). 
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was synthesized, corresponding to the human COMP sequence from 
1280-1363, using PCR with biotin-14-dCTP (PCR Nonradioactive 
Labeling System, Life Technologies) and oligonucleotides GCG 
GAT GTG GAC CAC GAC and GTC CCG AGA CTC CTG 
ATG TC. Nucleic acids were crosslinked to the nylon membranes 
with ultraviolet light (Stratalinker), blocked with herring sperm 
DNA, probed with the heat-denatured 84-base pair biotinylated-la-
beled probe to human COMP, and allowed to hybridize overnight at 
42°C. After washing, bound probe was detected using the Photogene 
Nucleic Acid Detection System (Life Technologies) according to the 
manufactures protocol. 
3. Results and discussion 
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Fig. 2. Western blot analysis of reduced purified articular cartilage 
COMP (cartilage) and synovial tissue extract (synovium) after 5-
15% gradient SDS-polyacrylamide gel electrophoresis using a rat 
monoclonal antibody to human COMP revealed a single identical 
molar mass band (approximately 110 kDa). 
Fig. 3. PCR using oligonucleotides that span human COMP exons 
7-13 revealed identical amplification products from cDNA prepared 
from either human chondrocytes (either fetal or adult) or synovium. 
human synovium. Immunostaining with either monoclonal 
or polyclonal antisera to human COMP revealed the presence 
of intensely positive COMP staining within synovial cells and 
the immediately subjacent connective tissue with less intense 
staining in the deeper connective tissue. There was no staining 
with rabbit preimmune serum or irrelevant rat monoclonal 
antibodies (controls) (Fig. 1). Synovium was also extracted 
with buffer containing EDTA. This method of extraction 
should preferentially extract COMP from the matrix, since it 
has been shown that COMP or its interaction partners are 
bound by a mediation with divalent cations [1-3]. Western 
blot analysis using either polyclonal or monoclonal antibodies 
to human COMP confirmed the presence of COMP by im-
munoreactive bands with the same molecular mass (approx-
imately 110 kDa) as purified articular human COMP (Fig. 2). 
PCR used on cDNA generated from articular cartilage chon-
drocytes and synovium mRNA revealed an amplification 
product of the same size (approximately 0.6 kb), correspond-
ing to the 622 base pairs of an internal COMP sequence (Fig. 
3). This region spans exons 7-13, thereby eliminating the pos-
sibility of contaminating DNA [13]. Northern blot analysis 
using either total RNA revealed identical hybridization prod-
ucts from synovium and articular chondrocytes, correspond-
ing to a product of the appropriate size (approximately 2.2 
kb) using a biotinylated-labeled double-stranded COMP 
DNA probe that also spans exons 12-13, also eliminating 
the possibility of contaminating DNA (Fig. 4). Human syno-
vium contains mRNA for COMP and produces protein, as 
noted by Western blot and immunostaining. 
The synovial membrane lines diarthroidal joints and con-
sists of an inner cellular layer (usually 2-A cells thick) and an 
outer layer of irregularly arranged connective tissue that are 
not separated by a basement membrane [14]. It has been pre-
viously shown that synovial cells have chondrogenic potential 
and can express cartilaginous extracellular matrix proteins 
and degradative enzymes [15-25]. 
The results of the present study indicate that synovium 
should be included as another tissue source of COMP, and 
may contribute to either synovial fluid or serum COMP levels. 
If COMP is to be developed as an accurate biological marker 
of cartilage metabolism, further studies are needed to deter-
mine the synthetic rate and deposition of COMP by human 
synovium and how these may change in various arthritic 
states. 
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Fig. 4. Northern blot analysis using a biotinylated-probe to human 
COMP, spanning exons 12-13, reveal an identical hybridization 
product to either human chondrocyte (cartilage) or synovium total 
RNA. 
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